Patient and public involvement
multimorbidity
No patients were involved in setting the research question or the outcome measures. General practitioners and patients aged ≥65 years with multimorbidity and polypharmacy were represented in the Safety and Data Monitoring Board. General practitioners and patients who participated in the trial received newsletters throughout the trial.